I

Interius BioTherapeutics

51 employees

Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical
Biopharma

Date founded

2019

Funding rounds raised

Total raised

$76M

from 9 investors over 9 rounds

I

Interius BioTherapeutics raised $76M on May 18, 2021

Investors: Tellus BioVentures, Knollwood Investment Advisory, Quan Capital 泉创资本, Longwood Fund, Logos Global Management, LP, RA Capital Management, L.P. and Osage University Partners (OUP)

I

Interius BioTherapeutics raised $5.5M on March 13, 2020

Investors: Tellus BioVentures and Agent Capital

FAQ